£131.24

It has never been this cheap. We have no record of a lower price.

£131 today · cheaper than every other day in the last 3 months

Springer Pharmacokinetics in Drug Development: Problems and Challenges in Oncology, Volume 4

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical
Generating forecast…
£131.24 £124.68 £127.30 £129.93 £132.55 £135.18 £137.80 25 July 2026 10 August 2026 27 August 2026 13 September 2026 30 September 2026
View at Amazon ↗

Price data last checked 23 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 68 days • 1 price levels

Days at Price
68 days 0 17 34 51 68 £131 Days at Price

Price Analysis

Most common price: £131 (68 days, 100.0%)

Price range: £131 - £131

Price levels: 1 different prices over 68 days

Description
In this volume, the specific challenges and problems facing the evaluation of new oncology agents are explored with regards to pharmacokinetic, pharmacodynamic modeling and clinical pharmacology development strategies. This book delivers, with an emphasis on the oncology therapeutic area, the goals set in the first three volumes: namely – to provide clinical pharmacologists practical insights for the application of pharmacology, pharmacokinetics and pharmacodynamics for new drug development strategies. Pharmacokinetic-pharmacodynamic concepts for tyrosine kinases, the evaluation of cardiac repolarization prolongation through QTc interval effects, efficacy- and safety-response analyses to support new drug approvals, clinical and preclinical tumor growth modeling, and flat- vs weight-based dose selection are showcased from an oncology clinical pharmacologist’s point-of-view. Oncology development strategies are surveyed for new FDA-approvals to identify patterns in expectations at time of first approval. The special considerations necessary to address combination drug development, metronomics, biosimilars and breakthrough therapies are also presented.

Product Specifications
Brand
Springer
Format
hardcover
ASIN
3319390511
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain
Amazon UK
Release Date
13 October 2016
Listed Since
13 April 2016

Barcode

No barcode data available